|
市場調査レポート
商品コード
1485097
非PVC静注バッグ市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、材料別、内容物別、地域別、競合別、2019-2029年Non-PVC IV Bags Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Material, By Content, By Region and Competition, 2019-2029F |
||||||
カスタマイズ可能
|
|||||||
| 非PVC静注バッグ市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、材料別、内容物別、地域別、競合別、2019-2029年 |
|
出版日: 2024年05月24日
発行: TechSci Research
ページ情報: 英文 187 Pages
納期: 2~3営業日
|
全表示
- 概要
- 目次
非PVC静注バッグの世界市場規模は2023年に19億5,000万米ドルで、予測期間では2029年までCAGR 8.54%で着実な成長が予測されています。
非PVC静注バッグ市場は、ポリ塩化ビニル(PVC)を使用せずに製造される静脈内(IV)バッグの製造と流通に焦点を当てた世界市場セクターを指します。ポリ塩化ビニル(PVC)の環境・健康への影響や廃棄への懸念から、従来の点滴バッグの代替品として注目されています。非PVC静注バッグは、ポリプロピレン、エチレンビニルアセテート(EVA)、その他の安全なプラスチック配合などの素材を使用して作られており、製造や廃棄の過程における有害物質の放出を低減しています。これらの製品の市場を牽引しているのは、より安全な医療材料に対する需要の高まりと、フタル酸エステルなどのPVC関連化合物に関連するリスクに対する意識の高まりです。
| 市場概要 | |
|---|---|
| 予測期間 | 2025-2029 |
| 市場規模:2023年 | 19億5,000万米ドル |
| 市場規模:2029年 | 31億7,000万米ドル |
| CAGR:2024年-2029年 | 8.54% |
| 急成長セグメント | マルチチャンバー |
| 最大市場 | 北米 |
市場促進要因
より安全な医療機器への需要の高まり
環境への関心の高まり
がん治療の増加
新興経済諸国におけるヘルスケアインフラの急速な発展
主な市場課題
標準化の欠如
代替ソリューションとの競合
主な市場動向
保管と安定性の向上
患者の安全性とケア基準
目次
第1章 概要
第2章 調査手法
第3章 エグゼクティブサマリー
第4章 顧客の声
第5章 世界の非PVC静注バッグ市場展望
- 市場規模・予測
- 金額別
- 市場シェア・予測
- 製品タイプ別(シングルチャンバー、マルチチャンバー)
- 材料別(エチレン酢酸ビニル、ポリプロピレン、共ポリエステルエーテル、その他)
- 内容物別(冷凍混合物、液体混合物)
- 地域別
- 企業別(2023)
- 市場マップ
第6章 北米の非PVC静注バッグ市場展望
- 市場規模・予測
- 金額別
- 市場シェア・予測
- 製品タイプ別
- 材料別
- 内容物別
- 国別
- 北米:国別分析
- 米国
- カナダ
- メキシコ
第7章 欧州の非PVC静注バッグ市場展望
- 市場規模・予測
- 金額別
- 市場シェア・予測
- 製品タイプ別
- 材料別
- 内容物別
- 国別
- 欧州:国別分析
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
第8章 アジア太平洋地域の非PVC静注バッグ市場展望
- 市場規模・予測
- 金額別
- 市場シェア・予測
- 製品タイプ別
- 材料別
- 内容物別
- 国別
- アジア太平洋地域:国別分析
- 中国
- インド
- 日本
- 韓国
- オーストラリア
第9章 南米の非PVC静注バッグ市場展望
- 市場規模・予測
- 金額別
- 市場シェア・予測
- 製品タイプ別
- 材料別
- 内容物別
- 国別
- 南米:国別分析
- ブラジル
- アルゼンチン
- コロンビア
第10章 中東・アフリカの非PVC静注バッグ市場展望
- 市場規模・予測
- 金額別
- 市場シェア・予測
- 製品タイプ別
- 材料別
- 内容物別
- 国別
- 中東・アフリカ:国別分析
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
第11章 市場力学
- 促進要因
- 課題
第12章 市場動向と発展
- 合併および買収(もしあれば)
- 製品の発売(もしあれば)
- 最近の動向
第13章 世界の非PVC静注バッグ市場:SWOT分析
第14章 ポーターのファイブフォース分析
- 業界内の競合
- 新規参入の可能性
- サプライヤーの力
- 顧客の力
- 代替品の脅威
第15章 競合情勢
- Baxter International Inc.
- B. Braun SE
- Pfizer Inc.
- Fresenius Kabi AG
- JW Life Science Corporation
- RENOLIT SE
- PolyCine GmbH
- Sealed Air Corporation
- Angiplast Pvt. Ltd
- Shanghai Solve Care Co. Ltd.
第16章 戦略的提言
第17章 調査会社について・免責事項
Global Non-PVC IV Bags Market was valued at USD 1.95 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 8.54% through 2029. The Non-PVC IV bags market refers to the global market sector focused on the production and distribution of intravenous (IV) bags that are made without using polyvinyl chloride (PVC). These bags are an alternative to the traditional IV bags due to concerns about the environmental and health impacts of PVC and its disposal. Non-PVC IV bags are created using materials such as polypropylene, ethylene-vinyl acetate (EVA), and other safer plastic formulations, which reduce the release of harmful substances during their manufacturing and disposal processes. The market for these products is driven by an increasing demand for safer medical materials and a growing awareness of the risks associated with PVC-related compounds, such as phthalates.
| Market Overview | |
|---|---|
| Forecast Period | 2025-2029 |
| Market Size 2023 | USD 1.95 Billion |
| Market Size 2029 | USD 3.17 Billion |
| CAGR 2024-2029 | 8.54% |
| Fastest Growing Segment | Multi Chamber |
| Largest Market | North America |
Key Market Drivers
Increasing Demand for Safer Medical Device
The increasing demand for safer medical device plays an important role in driving the growth of Global Non-PVC IV bags market. As the awareness among healthcare professionals and patients increased about the potential health risks associated with PVC IV bags. PVC bags contain plasticizers like DEHP, which can leach into the intravenous fluids and pose health risks, especially in vulnerable patient populations such as infants, pregnant women, and those undergoing long-term treatment. This awareness has led to a shift in preference towards safer alternatives like non-PVC IV bags. The National Academy of Sciences recommends that risks associated with phthalate exposure should be considered in terms of cumulative exposure to all phthalates and other antiandrogens. If an infant, toddler, or pregnant woman were exposed to her DEHP from medical devices, it would further increase her exposure to the existing chemical and may also affect the normal development of her reproductive tract. In healthcare industry the patient safety is a top priority. With reduced risk of leaching harmful chemicals non-PVC IV bags are considered safer. The adaptation of non-PVC IV bags was increased by healthcare providers and institutions to ensure the safety and well-being of their patients.
Increasing Environmental Concern
The increasing concern of environmental plays a significant role in driving the growth of Global Non-PVC IV bags Market. According to the World Health Organization (WHO), the pandemic requires 89 million masks, 30 million gowns, 1.59 million goggles and 76 million gloves each month. The outbreak of the pandemic has also generated large amounts of medical waste, including plastic. Polyvinyl chloride is a type of plastic that is non-biodegradable in nature and can stay in environment for hundreds of years, and the PVC IV bags are made from polyvinyl chloride. With the increasing concern of plastic pollution and its harmful effects on the environment has led to a demand for alternative materials. Non-PVC IV bags, which are often made from more environmentally friendly materials like polypropylene or polyethylene, offer a solution to reduce plastic waste in healthcare settings and anticipated in the growth of Global Non-PVC IV bags Market. Sustainable processes and materials were used in the manufacturing of non-PVC IV bags. This involves the use of renewable resources, such as plant-based polymers, and the reduction of energy consumption and greenhouse gas emissions during production. Healthcare providers and institutions are increasingly seeking out environmentally conscious products and suppliers, leading to the growth of the Global Non-PVC IV bags market.
Increasing in Cancer Treatment
The increase in Cancer treatment plays an important role in driving the growth of Global Non-PVC IV bags Market. Cancer is the second leading cause of death worldwide. Mostly common treatment for cancer is Chemotherapy, and several chemotherapy drugs are known to relate with PVC materials, potentially causing leaching of harmful substances. Non-PVC IV bags, which are made from alternative materials like polypropylene or polyethylene, are considered compatible with a wide range of chemotherapy drugs. This compatibility drives the demand for Non-PVC IV bags in cancer treatment settings. The also the leading to the growth of Global Non-PVC IV bags Market. Cancer patients undergoing treatment often require regular and long intravenous combinations. PVC IV bags may pose a risk of leaching chemicals, which can be harmful to patient safety and overall treatment outcomes. Non-PVC IV bags are considered a safer alternative as they have lower risks of leaching harmful substances. Non-PVC IV bags are often more flexible and lightweight, providing greater comfort to patients during treatment. The flexibility and comfort of use drives the growth of Global Non-PVC IV bags Market.
Rapidly Developing Healthcare Infrastructure in Emerging Economies
The burgeoning healthcare infrastructure in emerging economies has sparked a surge in demand for advanced medical equipment and supplies, notably non-PVC IV bags. As these countries experience rapid economic growth and urbanization, their healthcare systems are evolving to meet the needs of growing populations. Non-PVC IV bags are gaining prominence due to their superior safety profiles, reduced environmental impact, and compatibility with modern medical practices. Heightened awareness of the harmful effects of PVC materials on patients and the environment is driving healthcare providers to adopt alternatives. The global demand for non-PVC IV bags is therefore propelled not only by the expansion of healthcare infrastructure in emerging markets but also by a broader global trend towards sustainable and safer medical solutions. This growing demand underscores the necessity for manufacturers to innovate and expand production capacities to meet the evolving needs of healthcare systems worldwide.
Key Market Challenges
Lack of Standardization
The lack of standardization in healthcare practices and regulations across different regions is contributing to a decrease in the demand for non-PVC IV bags globally. Inconsistencies in standards regarding materials used in medical devices, including IV bags, create confusion and complexity for healthcare providers when selecting products. Without clear and uniform guidelines, providers may hesitate to adopt non-PVC IV bags, fearing potential regulatory issues or compatibility issues with existing systems. The absence of standardized protocols for evaluating the safety and efficacy of alternative materials like non-PVC further complicates the decision-making process for healthcare facilities. As a result, some providers may opt to stick with traditional PVC IV bags to avoid the uncertainties associated with transitioning to new materials. The lack of standardization can hinder the widespread adoption of Non-PVC IV bags in international markets, where varying regulatory requirements and preferences among healthcare systems present additional challenges. Therefore, until comprehensive and harmonized standards are established, the demand for non-PVC IV bags may continue to face obstacles globally, impeding their uptake despite their potential benefits in terms of safety and sustainability.
Competition from Alternative Solutions
The global demand for non-PVC IV bags faces challenges due to intensifying competition from alternative solutions within the medical device market. As healthcare providers seek safer and more sustainable options, manufacturers are diversifying their product offerings to include alternatives to traditional PVC IV bags. These alternatives may include newer materials or innovative designs that aim to address the same concerns regarding patient safety and environmental impact. With a growing array of options available, healthcare facilities are presented with more choices when selecting IV bags, potentially reducing the demand for non-PVC alternatives. The competitive landscape drives manufacturers to invest in improving the safety and performance of PVC IV bags, potentially narrowing the gap between PVC and Non-PVC options. Cost considerations play a significant role in decision-making for healthcare providers, and if alternative solutions offer comparable safety and performance at a lower cost, they may be favored over non-PVC IV bags. As a result, despite the advantages of non-PVC alternatives, competition from other solutions within the medical device market may dampen their demand globally, posing challenges for their widespread adoption in healthcare settings.
Key Market Trends
Improved Storage & Stability
The escalating demand for non-PVC IV bags on a global scale is significantly fueled by the imperative for improved storage and stability of medical solutions. These bags offer enhanced resilience to various storage conditions, ensuring the integrity and potency of intravenous fluids and medications over extended periods. This attribute becomes especially crucial in healthcare settings where maintaining consistent temperature control and reliable storage environments poses challenges. Non-PVC IV bags are designed to withstand a broader range of temperatures and environmental factors compared to traditional PVC alternatives, making them indispensable in regions with limited resources or volatile climates. Their compatibility with a diverse array of pharmaceuticals and reduced risk of leaching harmful substances further accentuates their appeal to healthcare providers worldwide. As the demand for pharmaceutical products grows and the need for reliable storage solutions intensifies, non-PVC IV bags emerge as a preferred choice for ensuring the efficacy and safety of intravenous therapies across diverse healthcare settings, thereby driving their global adoption and market expansion.
Patient Safety & Care Standards
The global demand for non-PVC IV bags is experiencing a notable surge due to the heightened focus on patient safety and care standards in healthcare systems worldwide. Non-PVC IV bags offer distinct advantages over traditional PVC alternatives, particularly concerning patient health and safety. PVC materials can leach harmful chemicals into intravenous fluids, posing risks to patient health, especially in vulnerable populations. In contrast, non-PVC IV bags are free from such risks, providing a safer option for administering medications and fluids. Healthcare facilities are increasingly prioritizing the adoption of medical devices and supplies that adhere to rigorous safety standards to ensure optimal patient care outcomes. Non-PVC IV bags align with these standards, offering healthcare providers peace of mind knowing that they are utilizing products that prioritize patient safety. As a result, the demand for non-PVC IV bags continues to grow globally as healthcare organizations strive to uphold the highest standards of patient safety and care, making them an essential component of modern healthcare systems around the world.
Segmental Insights
Product Type Insights
Based on product type, Multi Chamber have emerged as the fastest growing segment in the Global Non-PVC IV Bags Market during the forecast period. These innovative multi-chamber bags offer unparalleled versatility and safety by allowing the convenient separation of different types of medication until the point of administration, effectively reducing the risk of drug incompatibility and ensuring patient safety. Their growing prominence and adoption can be attributed to their exceptional functionality, especially in treatments requiring the sequential delivery of drugs. By enabling the sequential administration of multiple medications without the need for separate bags or complex procedures, these multi-chamber bags have emerged as a dominant player in the healthcare and pharmaceutical industries, revolutionizing the way medications are administered and enhancing patient care.
With their advanced design and remarkable features, multi-chamber bags have proven to be a game-changer in the medical field. Their ability to streamline the medication administration process, enhance efficiency, and mitigate potential risks make them an indispensable tool for healthcare professionals worldwide. As the demand for efficient drug delivery systems continues to grow, the significance and market presence of multi-chamber bags are set to further expand, propelling advancements in patient care and medication management.
Material Insights
Based on Material, Ethylene Vinyl Acetate holds a dominant position in the global non-PVC IV bags market, leading the charge as the preferred material for numerous healthcare providers worldwide. Its dominance is attributed to a multitude of excellent properties, such as exceptional flexibility, extremely low toxicity levels, and remarkable resistance to cracks, making it the ideal choice for a wide range of medical applications. EVA bags not only meet the stringent requirements of the healthcare industry but also have a significantly lesser environmental impact compared to their PVC counterparts. This alignment with the rising demand for sustainable and eco-friendly medical products further solidifies EVA's standing in the market. With its superior qualities and positive environmental attributes, EVA continues to revolutionize the non-PVC IV bags industry, shaping the future of healthcare with its unparalleled performance and commitment to sustainability.
Regional Insights
Based on region, the North American region exerted its dominance in the Global Non-PVC IV Bags Market. This can be attributed to several key factors that contribute to its strong position as a frontrunner in the global market. The region boasts an advanced healthcare infrastructure that enables efficient and effective delivery of medical services. With state-of-the-art hospitals, cutting-edge technology, and highly skilled healthcare professionals, North America ensures that patients receive top-notch care. There is a heightened awareness among healthcare professionals and the general population regarding the health and environmental risks associated with PVC. The harmful chemicals and toxins released by PVC IV bags have raised concerns about patient safety and environmental sustainability. As a result, there has been a significant shift towards non-PVC IV bags as a safer and more eco-friendly alternative.
Key Market Players
Baxter International Inc.
B. Braun SE
Pfizer Inc.
Fresenius Kabi AG
JW Life Science Corporation
RENOLIT SE
PolyCine GmbH
Sealed Air Corporation
Angiplast Pvt. Ltd
Shanghai Solve Care Co. Ltd.
Report Scope:
In this report, the Global Non-PVC IV Bags Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Non-PVC IV Bags Market, By Product Type:
-
Single Chamber
Multi Chamber
Non-PVC IV Bags Market, By Material:
-
Ethylene Vinyl Acetate
Polypropylene
Copolyster Ether
Others
Non-PVC IV Bags Market, By Content:
-
Frozen Mixture
Liquid Mixture
Non-PVC IV Bags Market, By Region:
-
North America
United States
Canada
Mexico
-
Europe
France
United Kingdom
Italy
Germany
Spain
-
Asia Pacific
China
India
Japan
Australia
South Korea
-
South America
Brazil
Argentina
Colombia
-
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Non-PVC IV Bags Market.
Available Customizations:
Global Non-PVC IV Bags Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validations
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Non-PVC IV Bags Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Product Type (Single Chamber, Multi Chamber)
- 5.2.2. By Material (Ethylene Vinyl Acetate, Polypropylene, Copolyster Ether, Others)
- 5.2.3. By Content (Frozen Mixture, Liquid Mixture)
- 5.2.4. By Region
- 5.2.5. By Company (2023)
- 5.3. Market Map
6. North America Non-PVC IV Bags Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Product Type
- 6.2.2. By Material
- 6.2.3. By Content
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Non-PVC IV Bags Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Product Type
- 6.3.1.2.2. By Material
- 6.3.1.2.3. By Content
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Non-PVC IV Bags Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Product Type
- 6.3.2.2.2. By Material
- 6.3.2.2.3. By Content
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Non-PVC IV Bags Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Product Type
- 6.3.3.2.2. By Material
- 6.3.3.2.3. By Content
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Non-PVC IV Bags Market Outlook
7. Europe Non-PVC IV Bags Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Product Type
- 7.2.2. By Material
- 7.2.3. By Content
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. United Kingdom Non-PVC IV Bags Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Product Type
- 7.3.1.2.2. By Material
- 7.3.1.2.3. By Content
- 7.3.1.1. Market Size & Forecast
- 7.3.2. Germany Non-PVC IV Bags Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Product Type
- 7.3.2.2.2. By Material
- 7.3.2.2.3. By Content
- 7.3.2.1. Market Size & Forecast
- 7.3.3. France Non-PVC IV Bags Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Product Type
- 7.3.3.2.2. By Material
- 7.3.3.2.3. By Content
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Non-PVC IV Bags Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Product Type
- 7.3.4.2.2. By Material
- 7.3.4.2.3. By Content
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Non-PVC IV Bags Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Product Type
- 7.3.5.2.2. By Material
- 7.3.5.2.3. By Content
- 7.3.5.1. Market Size & Forecast
- 7.3.1. United Kingdom Non-PVC IV Bags Market Outlook
8. Asia Pacific Non-PVC IV Bags Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Product Type
- 8.2.2. By Material
- 8.2.3. By Content
- 8.2.4. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Non-PVC IV Bags Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Product Type
- 8.3.1.2.2. By Material
- 8.3.1.2.3. By Content
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Non-PVC IV Bags Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Product Type
- 8.3.2.2.2. By Material
- 8.3.2.2.3. By Content
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Non-PVC IV Bags Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Product Type
- 8.3.3.2.2. By Material
- 8.3.3.2.3. By Content
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Non-PVC IV Bags Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Product Type
- 8.3.4.2.2. By Material
- 8.3.4.2.3. By Content
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Non-PVC IV Bags Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Product Type
- 8.3.5.2.2. By Material
- 8.3.5.2.3. By Content
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Non-PVC IV Bags Market Outlook
9. South America Non-PVC IV Bags Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Product Type
- 9.2.2. By Material
- 9.2.3. By Content
- 9.2.4. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Non-PVC IV Bags Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Product Type
- 9.3.1.2.2. By Material
- 9.3.1.2.3. By Content
- 9.3.1.1. Market Size & Forecast
- 9.3.2. Argentina Non-PVC IV Bags Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Product Type
- 9.3.2.2.2. By Material
- 9.3.2.2.3. By Content
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Colombia Non-PVC IV Bags Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Product Type
- 9.3.3.2.2. By Material
- 9.3.3.2.3. By Content
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Brazil Non-PVC IV Bags Market Outlook
10. Middle East and Africa Non-PVC IV Bags Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Product Type
- 10.2.2. By Material
- 10.2.3. By Content
- 10.2.4. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Non-PVC IV Bags Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Product Type
- 10.3.1.2.2. By Material
- 10.3.1.2.3. By Content
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Saudi Arabia Non-PVC IV Bags Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Product Type
- 10.3.2.2.2. By Material
- 10.3.2.2.3. By Content
- 10.3.2.1. Market Size & Forecast
- 10.3.3. UAE Non-PVC IV Bags Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Product Type
- 10.3.3.2.2. By Material
- 10.3.3.2.3. By Content
- 10.3.3.1. Market Size & Forecast
- 10.3.1. South Africa Non-PVC IV Bags Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Global Non-PVC IV Bags Market: SWOT Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. Baxter International Inc.
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
- 15.2. B. Braun SE
- 15.3. Pfizer Inc.
- 15.4. Fresenius Kabi AG
- 15.5. JW Life Science Corporation
- 15.6. RENOLIT SE
- 15.7. PolyCine GmbH
- 15.8. Sealed Air Corporation
- 15.9. Angiplast Pvt. Ltd
- 15.10. Shanghai Solve Care Co. Ltd.
